WO2006075253A3 - Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. - Google Patents
Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. Download PDFInfo
- Publication number
- WO2006075253A3 WO2006075253A3 PCT/IB2006/000559 IB2006000559W WO2006075253A3 WO 2006075253 A3 WO2006075253 A3 WO 2006075253A3 IB 2006000559 W IB2006000559 W IB 2006000559W WO 2006075253 A3 WO2006075253 A3 WO 2006075253A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- dander
- compositions containing
- dog hair
- subjects allergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
The present invention relates to peptides capable of desensitizing, in a specific manner, the great majority of subjects allergic to dog hair and dander, said peptides being defined by a sequence of 11 to 38 consecutive amino acids of a fragment of the mature Can f 1 protein which is selected from the group consisting of: the fragments from positions 3 to 30, 49 to 66 , 73 to 104, and 107 to 144, with the exclusion of the sequences from positions 15 to 26, 50 to 62 and 122 to 133, and to compositions containing said peptides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05290065.1 | 2005-01-11 | ||
EP05290065 | 2005-01-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006075253A2 WO2006075253A2 (en) | 2006-07-20 |
WO2006075253A3 true WO2006075253A3 (en) | 2006-11-30 |
Family
ID=34941886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/000559 WO2006075253A2 (en) | 2005-01-11 | 2006-01-11 | Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006075253A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2830940B1 (en) | 2001-10-17 | 2007-06-15 | Commissariat Energie Atomique | METHOD FOR SELECTING HLA-DP4 LIGANDS AND ITS APPLICATIONS |
GB0710529D0 (en) † | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
DK2153841T4 (en) | 2008-08-15 | 2016-02-15 | Circassia Ltd | Vaccine comprising Amb a 1 peptides for use in the treatment of ambrosieallergi |
WO2010018384A1 (en) | 2008-08-15 | 2010-02-18 | Circassia Limited | T-cell antigen peptide from allergen for stimulation of il-10 production |
EP2891662A1 (en) | 2009-02-05 | 2015-07-08 | Circassia Limited | Grass peptides for vaccine |
CN102663202A (en) * | 2012-04-25 | 2012-09-12 | 清华大学 | Dynamic product cooperative development platform and method based on federation mode |
CN102708234B (en) * | 2012-04-25 | 2014-08-27 | 清华大学 | Integration platform and method of Matlab (matrix laboratory) simulation model based on HLA (high level architecture) |
CN102663203B (en) * | 2012-04-25 | 2014-09-24 | 清华大学 | Fortran simulation model middleware based on high level architecture (HLA) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994016068A2 (en) * | 1992-12-31 | 1994-07-21 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from dog dander and uses therefor |
-
2006
- 2006-01-11 WO PCT/IB2006/000559 patent/WO2006075253A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994016068A2 (en) * | 1992-12-31 | 1994-07-21 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from dog dander and uses therefor |
Non-Patent Citations (8)
Title |
---|
CHAPMAN M D ET AL: "RECOMBINANT ALLERGENS FOR DIAGNOSIS AND THERAPY OF ALLERGIC DISEASE", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY - YEARLY BOOK, INC, US, vol. 106, no. 3, 2000, pages 409 - 418, XP001016248, ISSN: 0091-6749 * |
DATABASE EMBL 3 March 2000 (2000-03-03), XP002323321, retrieved from EBI Database accession no. AF027177 * |
DATABASE UniProt 15 June 1998 (1998-06-15), XP002323320, retrieved from EBI Database accession no. O18873 * |
KONIECZNY A ET AL: "THE MAJOR DOG ALLERGENS, CAN F1 AND CAN F2, ARE SALIVARY LIPOCALIN PROTEINS: CLONING AND IMMUNOLOGICAL CHARACTERIZATION OF THE RECOMBINANT FORMS", IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBLICATIONS, GB, vol. 92, 1997, pages 577 - 586, XP000915647, ISSN: 0019-2805 * |
MUELLER U ET AL: "SUCCESSFUL IMMUNOTHERAPY WITH T-CELL EPITOPE PEPTIDES OF BEE VENOM PHOSPHOLIPASE A2 INDUCES SPECIFIC T-CELL ANERGY IN PATIENTS ALLERGIC TO BEE VENOM", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY - YEARLY BOOK, INC, US, vol. 101, June 1998 (1998-06-01), pages 747 - 754, XP000857365, ISSN: 0091-6749 * |
OLDFIELD W L G ET AL: "Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial", LANCET, vol. 360, no. 9326, 6 July 2002 (2002-07-06), pages 47 - 53, XP004369656, ISSN: 0140-6736 * |
THOMAS W R ET AL: "CLONING AND EXPRESSION OF DNA CODING FOR THE MAJOR HOUSE DUST MITE ALLERGEN DER P 1 IN ESCHERICHIA COLI", INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, BASEL, CH, vol. 85, January 1988 (1988-01-01), pages 127 - 129, XP002021266, ISSN: 0020-5915 * |
VALENTA R ET AL: "RECOMBINANT ALLERGENS AS CANDIDATES FOR IMMUNOTHERAPY OF TYPE I ALLERGIC DISEASES", VACCINES : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, COLD SPRING HARBOR LABORATORY PRESS, NEW YORK, US, 1993, pages 37 - 42, XP009040109 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006075253A2 (en) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006075253A3 (en) | Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. | |
MXPA06001283A (en) | Novel insulin derivatives. | |
EP2368907A3 (en) | Anti-Abeta antibodies and their use | |
UA97473C2 (en) | Normal;heading 1;heading 2;heading 3;ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF | |
MX348154B (en) | IL-1ß BINDING ANTIBODIES AND FRAGMENTS THEREOF. | |
WO2005115306A3 (en) | Keratin-binding polypeptides | |
WO2006087550A3 (en) | Amyloid-binding peptides, analogues and uses thereof | |
WO2007146269A3 (en) | Peptide fragments for inducing synthesis of extracellular matrix proteins | |
WO2008074840A3 (en) | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders | |
WO2008057463A3 (en) | Peptide-based conditioners | |
WO2007064917A3 (en) | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | |
WO2008081701A1 (en) | Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same | |
WO2006054262A3 (en) | Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof | |
WO2004081028A3 (en) | Allergen peptide fragments and use thereof | |
WO2007039231A3 (en) | Method of producing a modified (poly)peptide | |
WO2008093058A3 (en) | Peptides and their use | |
WO2007029262A3 (en) | Compositions and methods using same for the detection of viruses | |
ATE506957T1 (en) | PROPHYLACTIC/THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASES | |
WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
WO2010142551A8 (en) | Amino acid sequences directed against receptors to cytokines belonging to the il-17 family | |
WO2006097432A3 (en) | Keratin-binding desmoplakin polypeptide sequences | |
EP1982992A4 (en) | Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector | |
EP1842911A4 (en) | Hla-binding peptides, dna fragments encoding the same and recombinant vectors | |
WO2005072766A3 (en) | Peptides that bind to hsp90 proteins | |
EP1757687A4 (en) | Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06710545 Country of ref document: EP Kind code of ref document: A2 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6710545 Country of ref document: EP |